Search Results
10
Everything
Allogeneic CAR-T Cell Patent Landscape and Forecast Report 2024-2032, Profiles of Artiva Biotherapeutics, Poseida Therapeutics, Nanjing Beiheng Biological Technology, NantCell, GC Cell, BMS, Compugen
March 13, 2025 11:02 ET
|
Research and Markets
Dublin, March 13, 2025 (GLOBE NEWSWIRE) -- The "Allogeneic CAR-T Cell Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The global allogenic...
Immunotherapy in Oncology Patent Landscape Report and Forecast 2024-2032: Identify Emerging Therapeutic Targets and Assess the Competitive Landscape
March 06, 2025 11:00 ET
|
Research and Markets
Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Immunotherapy in Oncology Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The...
TCR Therapy Pipeline Market Landscape Report 2025: Progress, Innovations and Developments
March 05, 2025 10:35 ET
|
Research and Markets
Dublin, March 05, 2025 (GLOBE NEWSWIRE) -- The "TCR Therapy - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering.The T-cell receptor (TCR) therapy landscape has been...
Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Pipeline Market Research 2025: Global Advancements Poised to Transform Oncology Landscape
March 04, 2025 10:49 ET
|
Research and Markets
Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Chimeric Antigen Receptor T-Cell Therapy (CAR-T) - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. The Chimeric...
CAR T-Cell Therapy Market Forecasts to 2035, with Competitor Profiles of Autolus, Bluebird Bio, Carsgen Therapeutics, Cellectis, Noile-Immune Biotech, Shanghai GeneChem, Takara Bio and More
February 05, 2025 07:45 ET
|
Research and Markets
Dublin, Feb. 05, 2025 (GLOBE NEWSWIRE) -- The "CAR T-Cell Therapy Market Industry Trends and Global Forecasts to 2035" report has been added to ResearchAndMarkets.com's offering. The global CAR...
Cancer Immunotherapy Market, Valued at $125.68 Billion in 2025, Sees $194.64 Billion Opportunity by 2029 - Dominated by Amgen, AstraZeneca, Roche, Bayer, and Eli Lilly
January 28, 2025 11:29 ET
|
Research and Markets
Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Market Report 2025" has been added to ResearchAndMarkets.com's offering.This Cancer Immunotherapy market report covers market...
Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Research 2024-2033: Robust Growth Fueled by Disease Prevalence and Therapy Approvals, AI and Real-time Testing Trends Set to Shape Future
January 16, 2025 07:41 ET
|
Research and Markets
Dublin, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Cell and Gene Therapy Manufacturing QC Market: Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's...
Cell Therapy Technologies Market Forecasts 2024-2029: Advancements in Gene Editing Technologies, Development of Automated Cell Processing Systems and Regulatory Support for Fast-tracking Therapies
January 16, 2025 04:43 ET
|
Research and Markets
Dublin, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The "Cell Therapy Technologies Market by Product (Media, Sera & Reagents, Vessels, Single-Use Equipment), Process (Cell Processing, Preservation,...
Cancer Immunotherapy Global Market Overview 2023-2030, Competitive Analysis of Amgen, AstraZeneca,Bayer, BMS, Eli Lilly, F. Hoffmann-La Roche, GSK, Immunocore, J&J, Merck, Novartis, Pfizer
January 10, 2025 04:06 ET
|
Research and Markets
Dublin, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The global market for Cancer Immunotherapy...
Rapid Rise of Synthetic Biology Fuels Enzymatic DNA Synthesis Boom Across Biopharma and Genomics
January 09, 2025 11:38 ET
|
Research and Markets
Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Enzymatic DNA Synthesis Market by Service, by Application, by End-User, and By Region" report has been added to ResearchAndMarkets.com's offering.The...